Aurinia Pharmaceuticals

YTD

ALL

Trade Aurinia Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

CEO

Peter S. Greenleaf

CEOPeter S. Greenleaf

Employees

130

Employees130

Headquarters

Edmonton, Alberta

HeadquartersEdmonton, Alberta

Founded

1993

Founded1993

Employees

130

Employees130

AUPH Key Statistics

Market cap

1.08B

Market cap1.08B

Price-Earnings ratio

29.15

Price-Earnings ratio29.15

Dividend yield

—

Dividend yield—

Average volume

1.08M

Average volume1.08M

High today

$8.20

High today$8.20

Low today

$7.92

Low today$7.92

Open price

$8.03

Open price$8.03

Volume

1.47M

Volume1.47M

52 Week high

$10.67

52 Week high$10.67

52 Week low

$5.20

52 Week low$5.20

AUPH News

Simply Wall St 5d

Shareholders in Aurinia Pharmaceuticals have lost 50%, as stock drops 5.0% this past week

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But in any portfolio, there wil...

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own AUPH. This list is generated using Robinhood data, and it’s not a recommendation.